Report on the 4th European Breast Cancer Conferenc...[Breast Cancer Res. 2004]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Breast Cancer Res. 2004;6(4):148-52. Epub 2004 May 18. Links

Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004.

Senkus-Konefka E, Jassem J.

Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland. elsenkus@amg.gda.pl

The 4th European Breast Cancer Conference, organized under the auspices of the European Organization for Research and Treatment of Cancer Breast Cancer Group, of the European Breast Cancer Coalition (Europa Donna) and of the European Society of Mastology (EUSOMA), was held in Hamburg, Germany on 16-20 March 2004. The leading theme of the conference was partnership among scientists, clinicians, carers, advocates and patients. The present article provides a brief description of the most important conference presentations on molecular biology, epidemiology, prevention, pathology, diagnosis and treatment at all stages of breast cancer.

PMID: 15217485 [PubMed - indexed for MEDLINE]

PMCID: PMC468656

ReviewReducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Clin Ther. 2007 Aug; 29(8):1535-47.

[Clin Ther. 2007]
ReviewExtended adjuvant therapy with letrozole: reducing the risk of recurrence.
Expert Rev Anticancer Ther. 2006 Jun; 6(6):849-59.

[Expert Rev Anticancer Ther. 2006]
ReviewHormonal therapies for early breast cancer: systematic review and economic evaluation.
Health Technol Assess. 2007 Jul; 11(26):iii-iv, ix-xi, 1-134.

[Health Technol Assess. 2007]
ReviewOverview of resistance to systemic therapy in patients with breast cancer.
Adv Exp Med Biol. 2007; 608:1-22.

[Adv Exp Med Biol. 2007]
ReviewThe evolving role of aromatase inhibitors in adjuvant breast cancer therapy.
Clin Breast Cancer. 2005 Aug; 6(3):206-15.

[Clin Breast Cancer. 2005]
» See reviews... | » See all...

Patient Drug Information

Progesterone (Prometrium® )
Progesterone is used as a part of hormone replacement therapy in women who have passed menopause (the change of life) and have not had a hysterectomy (surgery to remove the uterus). Hormone replacement therapy usually in...
Tamoxifen (Nolvadex® )
Your doctor has prescribed tamoxifen for you. Tamoxifen comes as a tablet to take by mouth.
Medroxyprogesterone (Provera® , Premphase® as a combination product containing Medroxyprogesterone Acetate, Conjugated Estrogens, and Conjugated Estrogens, Prempro® as a combination product containing Medroxyprogesterone Acetate and Conjugated Estrogens)
Medroxyprogesterone is used to treat abnormal menstruation (periods) or irregular vaginal bleeding. Medroxyprogesterone is also used to bring on a normal menstrual cycle in women who menstruated normally in the past but ...
Source: AHFS Consumer Medication Information

Recent Activity

Clear Turn Off Turn On

Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004.Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004.

Related articles

Patient Drug Information

Recent Activity